ALFA Finder| Revenue growth | Standalone revenue grew 8% QoQ but declined 19% YoY. |
|---|---|
| Margins | Standalone EBITDA margins at 46%; HALS EBITDA turned positive at ₹8cr. |
| Demand visibility | Improving volume offtake in core products despite global geopolitical uncertainties. |
| Management confidence | Balanced; cautious on macro but aggressive on HALS segment expansion. |
Growth
Standalone revenue grew 8% QoQ to ₹193cr, while HALS segment hit record revenues, shifting from 20% to 50% exports.
Outlook
Capex of ₹80-100cr planned for FY27; Performance Chemicals 2 commercialization expected by September 2026.
Risks
Chinese dumping of MEHQ and volatile raw materials (phenol/acetone) remain significant threats to pricing stability and margins.
Earnings Call filed with BSE, NSE: CLEAN. Summary written with AI assistance from the document.
Clean Science & Technology Ltd: key numbers
- Share price
- ₹714.00
- Market cap
- ₹7,589 Cr
- Revenue (annual)
- ₹956.5 Cr
- Net profit (annual)
- ₹229.7 Cr
- P/E (TTM)
- 32.5×Sector 35.5×
- Promoter holding
- 51.29%+0.00% QoQ
- FII holding
- 13.72%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Clean Science & Technology Ltd
All →Clean Science & Technology Earnings Call Transcript: Key Takeaways
Record consolidated quarter, with HALS revenue doubling YoY. Standalone margins compressed as raw-material inflation could not be passed on to customers.
Clean Science & Technology Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹299 Cr (+22% YoY), PAT ₹56 Cr (+0.5%), EBITDA margin 31.2% (vs 36.4%). HALS-led growth; margins hit by geopolitical headwinds.
Clean Science & Technology Q2 FY27 Results: Net Profit ₹55.7 Cr, Up 0.5% YoY
Clean Science & Technology Ltd reported revenue from operations of ₹299.4 Cr (+22.4% YoY) and net profit of ₹55.7 Cr (+0.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹55.7 Cr · +0.5% YoY
Clean Science & Technology Business Update
Clean Science's subsidiary Clean Fino-Chem completed product trials for advanced HALS grades developed with Geneus Chem AG. Commercial launch of the new range is expected in H2 FY2026-27.
Clean Science & Technology Other Announcement
Clean Science and Technology Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
Clean Science & Technology Board Meeting Date
Clean Science and Technology Ltd has scheduled a board meeting for October 31, 2026, to approve unaudited financial results for the quarter and half year ending September 2026.